Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248885 · ClinicalTrials.gov registry record · NA
Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT00248885 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 248 participants.
The verdict
NCT00248885, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
It is the long term objective of this study to preserve or improve the quality of life and to prevent deterioration in physical and mental function following myocardial revascularization among bypass surgery patients.
Interventions
- PROCEDURE Regulating Mean Arterial Pressure during cardiopulmonary bypass
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 1991-09 |
| Est. Completion | 1994-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00248885
The ClinicalTrials.gov registry entry for NCT00248885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Regulating Mean Arterial Pressure during cardiopulmonary bypass is the first listed.
NCT00248885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00248885 about?
NCT00248885 is a clinical study titled "Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)". It is the long term objective of this study to preserve or improve the quality of life and to prevent deterioration in physical and mental function following myocardial revascularization among bypass surgery patients.
What is the current status of trial NCT00248885?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 1991-09. Estimated completion is 1994-09.
What interventions are being tested in trial NCT00248885?
The interventions under investigation include: Regulating Mean Arterial Pressure during cardiopulmonary bypass (PROCEDURE).
Who is sponsoring clinical trial NCT00248885?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.